Highlights in Science Engineering and Technology,
Journal Year:
2022,
Volume and Issue:
8, P. 396 - 405
Published: Aug. 17, 2022
Alzheimer's
disease
(AD)
is
a
characterized
by
memory
impairment,
loss
of
words
and
inability
in
emotional
control
that
occurs
the
early
intermediate
stage
end
our
lives.
A
number
studies
have
shown
incidence
severity
AD
higher
patients
with
sleep
disorders
than
healthy
people.
The
pathogenic
mechanism
still
inconclusive,
while
several
hypotheses
been
proposed
according
to
its
etiological
characteristics:
Some
suggest
β-amyloid
protein
hypothesis
abnormal
phosphorylation
tau
induced
may
be
key
factors
leading
AD.
This
paper
will
summarize
mechanisms
discuss
current
therapies
approaches
it,
which
included
pharmacological
therapy,
using
Trazodone,
Midazolam
Maleate
tablets,
Gardenia
Citrusaurantium
capsules
as
well
non-pharmacological
use
aerobic
exercise
light
promoting
idea
relieving
an
adjunctive
treatment
for
contents
summarized
this
some
significance
reference
direction
disorders.
Inflammatory
responses,
manifested
in
excessive
oxidative
stress
and
microglia
overactivation,
together
with
metal
ion-triggered
amyloid-beta
(Aβ)
deposition,
are
critical
hallmarks
of
Alzheimer’s
disease
(AD).
The
intricate
pathogenesis
causes
severe
impairment
neurons,
which,
turn,
exacerbates
Aβ
aggregation
facilitates
AD
progression.
Herein,
multifunctional
melanin-like
ion
chelators
neuroinflammation
regulators
(named
PDA@K)
were
constructed
for
targeted
treatment
AD.
In
this
platform,
intrinsically
bioactive
material
polydopamine
nanoparticles
(PDA)
potent
chelating
ROS
scavenging
effects
decorated
the
KLVFF
peptide,
endowing
system
capacity
enhanced
pathological
blood–brain
barrier
(BBB)
crossing
lesion
site
accumulation
via
hitchhiking.
vitro
vivo
experiment
revealed
that
PDA@K
had
high
affinity
toward
able
to
hitch
a
ride
on
achieve
increased
BBB
crossing.
engineered
effectively
mitigated
aggregate
alleviated
neuroinflammation.
modulated
inflammatory
microenvironment
by
promoted
microglial
polarization
M2-like
phenotype,
which
restored
their
functions
neuron
care
plaque
removal.
After
3-week
PDA@K,
spatial
learning
memory
deficit
as
well
neurologic
changes
FAD
4T
transgenic
mice
largely
rescued.
Transcriptomics
analysis
further
therapeutic
mechanism
PDA@K.
Our
study
provided
an
appealing
paradigm
directly
utilizing
intrinsic
properties
nanomaterials
therapeutics
instead
just
using
them
nanocarriers,
widen
application
therapy.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: Aug. 25, 2023
Alzheimer's
disease,
the
most
common
age-related
neurodegenerative
is
characterized
by
tau
aggregation
and
associated
with
disrupted
circadian
rhythms
dampened
clock
gene
expression.
REV-ERBα
a
core
protein
which
also
serves
as
nuclear
receptor
transcriptional
repressor
involved
in
lipid
metabolism
macrophage
function.
Global
deletion
has
been
shown
to
promote
microglial
activation
mitigate
amyloid
plaque
formation.
However,
cell-autonomous
effects
of
healthy
brain
tauopathy
are
unexplored.
Here,
we
show
that
enhances
inflammatory
signaling,
disrupts
metabolism,
causes
droplet
(LD)
accumulation
specifically
male
microglia.
These
events
impair
phagocytosis,
can
be
partially
rescued
blockage
LD
In
vivo,
exacerbates
neuroinflammation
two
mouse
models,
mice.
data
demonstrate
importance
droplets
reveal
therapeutically
accessible,
sex-dependent
regulator
tauopathy.
Acta Physiologica,
Journal Year:
2023,
Volume and Issue:
238(2)
Published: March 31, 2023
Abstract
Dysfunction
of
circadian
and
sleep
rhythms
is
an
early
feature
many
neurodegenerative
diseases.
Alzheimer's
disease
(AD)
a
progressive
disorder
resulting
in
cognitive
psychiatric
disturbances.
Although
it
largely
unclear
whether
dysfunctions
contribute
to
the
etiology
AD
or
are
consequence
disease,
there
evidence
that
these
conditions
involved
complex
self‐reinforcing
bidirectional
relationship.
According
recent
studies,
dysregulation
clock
already
occurs
during
asymptomatic
stage
could
promote
neurodegeneration.
Thus,
restoration
preclinical
may
represent
opportunity
for
intervention
slow
course.
Journal of Sleep Research,
Journal Year:
2023,
Volume and Issue:
32(4)
Published: March 15, 2023
Summary
Obstructive
sleep
apnea
is
the
most
common
sleep‐related
breathing
disorder
worldwide
and
remains
underdiagnosed.
Its
multiple
associated
comorbidities
contribute
to
a
decreased
quality
of
life
work
performance
as
well
an
increased
risk
death.
Standard
treatment
seems
have
limited
effects
on
cardiovascular
metabolic
aspects
disease,
emphasising
need
for
early
diagnosis
additional
therapeutic
approaches.
Recent
evidence
suggests
that
dysregulation
circadian
rhythms,
processes
with
endogenous
rhythmicity
are
adjusted
environment
through
various
cues,
involved
in
pathogenesis
comorbidities.
In
patients
obstructive
apnea,
altered
gene
expression
patterns
been
demonstrated.
respiratory
events
may
promote
disturbance
intermittent
hypoxia,
subsequent
inflammation
disruption
neural
hormonal
homeostasis.
this
review,
current
knowledge
rhythm
regulation,
disorders
summarised.
Studies
connect
abnormalities
critically
evaluated.
Furthermore,
pathogenetic
mechanisms
underlie
association,
notably
hypoxia
signalling,
presented.
A
bidirectional
relationship
between
proposed.
Approaching
prove
beneficial
development
new,
personalised
diagnostic,
prognostic
tools.
However,
further
studies
needed
before
clinical
approach
includes
targeting
system.
Journal of Human Hypertension,
Journal Year:
2024,
Volume and Issue:
38(5), P. 420 - 429
Published: Jan. 11, 2024
Chronic
kidney
disease
(CKD)
represents
a
significant
global
burden.
Hypertension
is
modifiable
risk
factor
for
rapid
progression
of
CKD.
We
extend
the
stratification
by
introducing
non-parametric
determination
rhythmic
components
in
24-h
profiles
ambulatory
blood
pressure
monitoring
(ABPM)
Renal
Insufficiency
Cohort
(CRIC)
and
African
American
Study
Kidney
Disease
(AASK)
cohort
using
Cox
proportional
hazards
models.
find
that
profiling
BP
through
JTK_CYCLE
analysis
identifies
subgroups
CRIC
participants
were
more
likely
to
die
due
cardiovascular
causes.
While
our
fully
adjusted
model
shows
trend
towards
association
between
absent
cyclic
death
full
(HR:
1.71,95%
CI:
0.99-2.97,
p
=
0.056),
with
history
(CVD)
their
profile
had
at
any
time
3.4-times
higher
than
CVD
patients
present
3.37,
95%
1.45-7.87,
0.005).
This
increased
was
not
explained
dipping
or
non-dipping
pattern
ABPM.
Due
large
differences
patient
characteristics,
results
do
replicate
AASK
cohort.
study
suggests
as
potential
novel
biomarker
unmask
excess
among
CKD
prior
disease.
Frontiers in Neural Circuits,
Journal Year:
2023,
Volume and Issue:
16
Published: Jan. 19, 2023
The
circadian
clock
plays
a
prominent
role
in
neurons
during
development
and
throughout
aging.
This
review
covers
topics
pertinent
to
the
of
24-h
rhythms
neuronal
function,
their
tendency
decline
with
Pharmacological
or
behavioral
modification
that
augment
function
our
internal
may
be
central
cognitive
disease
future
chronotherapy
for
aging-related
diseases
nervous
system.
PLoS Genetics,
Journal Year:
2023,
Volume and Issue:
19(8), P. e1010904 - e1010904
Published: Aug. 28, 2023
The
molecular
circadian
clock,
which
controls
rhythmic
24-hour
oscillation
of
genes,
proteins,
and
metabolites
in
healthy
tissues,
is
disrupted
across
many
human
cancers.
Deregulated
expression
the
MYC
oncoprotein
has
been
shown
to
alter
clock
leading
a
disruption
cancer
types.
It
remains
unclear
what
benefit
cells
gain
from
suppressing
oscillation,
how
this
loss
impacts
global
gene
metabolism
cancer.
We
hypothesized
that
or
its
paralog
N-MYC
(collectively
termed
herein)
suppress
upregulate
pathways
involved
biosynthesis
static,
non-oscillatory
fashion.
To
test
this,
distinct
types
with
inducible
were
examined,
using
time-series
RNA-sequencing
metabolomics,
determine
extent
activation
disrupts
pathways,
metabolites.
focused
our
analyses
on
changed
common
multiple
cell
line
models.
report
here
over
85%
oscillating
while
instead
promoting
enhanced
ribosomal
mitochondrial
biogenesis
suppressed
attachment
pathways.
Notably,
when
activated,
biosynthetic
programs
formerly
flipped
being
upregulated
an
oscillation-free
manner.
Further,
ablates
nutrient
transporter
proteins
greatly
upregulating
expression,
surface
localization,
intracellular
amino
acid
pools.
Finally,
we
metabolite
oscillations
temporal
segregation
nucleotide
metabolism.
Our
results
demonstrate
releases
metabolic
processes
control,
may
provide
advantage
cells.